Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Schindel Yair Chaim — ACETO CORP insider: 2 transactions · InsiderLens

Home / Insiders / Schindel Yair Chaim

Schindel Yair Chaim

shareholder of 10% holder at Seer, Inc. · on record since Jun 11, 2021
Director at ACETO CORP · on record since Sep 17, 2020
10% owner at Seer, Inc. · on record since Dec 10, 2020
10% owner at SUNESIS PHARMACEUTICALS INC · on record since Feb 25, 2021
10% owner at Advaxis, Inc. · on record since Jan 30, 2023
shareholder of 10% holder at Ayala Pharmaceuticals, Inc. · on record since Jan 24, 2023

Insider trading activity of Schindel Yair Chaim

Transactions on record: 2; since Sep 17, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Sep 17, 2020

Figures computed from official regulatory filings — methodology.

Companies where Schindel Yair Chaim has traded

ACETO CORP2 tx · Sep 17, 2020

Track record of Schindel Yair Chaim

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Schindel Yair Chaim

Co-insiders of Schindel Yair Chaim

aMoon 2 Fund Limited PartnershipAdvaxis, Inc. +3
Bisker-Leib VeredAdvaxis, Inc. +1
GOLDBERG MURRAY AAdvaxis, Inc. +1
Israel Biotech Fund I, L.P.Advaxis, Inc. +1
SIDRANSKY DAVIDAdvaxis, Inc. +1
Spiegel Robert J.Advaxis, Inc. +1
ABBOT STEWARTACETO CORP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Adage Capital Advisors, L.L.C.Advaxis, Inc.

ADAGE CAPITAL PARTNERS GP LLCAdvaxis, Inc.

ADAGE CAPITAL PARTNERS LPAdvaxis, Inc.

ADELMAN DANIEL C MDSUNESIS PHARMACEUTICALS INC

Aftab BlakeACETO CORP

AINSLIE LEE S IIISeer, Inc.

Aisling Capital IV, LPSUNESIS PHARMACEUTICALS INC

Aisling Capital Partners IV LLCSUNESIS PHARMACEUTICALS INC

Aisling Capital Partners IV, LPSUNESIS PHARMACEUTICALS INC

Alaimo Charles JohnACETO CORP

ALTA BIOPHARMA MANAGEMENT III LLCSUNESIS PHARMACEUTICALS INC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGSUNESIS PHARMACEUTICALS INC

ALTA BIOPHARMA PARTNERS III LPSUNESIS PHARMACEUTICALS INC

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCSUNESIS PHARMACEUTICALS INC

APPEL RONIAdvaxis, Inc.

ARTAL GROUP S ASeer, Inc.

Artal International Management S.A.Seer, Inc.

ARTAL INTERNATIONAL SCASeer, Inc.

Artal Treasury LtdSeer, Inc.

Atchinson RobertAdvaxis, Inc.

AUKEN WENDELL G VAN IIISUNESIS PHARMACEUTICALS INC

Barlow Jane FSUNESIS PHARMACEUTICALS INC

BARRETT M JAMESSUNESIS PHARMACEUTICALS INC

BARRIS PETER JSUNESIS PHARMACEUTICALS INC

Bartone RaymondACETO CORP

BASKETT FORESTSUNESIS PHARMACEUTICALS INC

Bay City Capital Fund V Co-Investment Fund LPSUNESIS PHARMACEUTICALS INC

Bay City Capital Fund V, L.P.SUNESIS PHARMACEUTICALS INC

BAY CITY CAPITAL LLCSUNESIS PHARMACEUTICALS INC

Bay City Capital Management V LLCSUNESIS PHARMACEUTICALS INC

Bazarko Anthony R.Seer, Inc.

Bender UlfACETO CORP

BERGERON WILLIEACETO CORP

Berlin Kenneth AAdvaxis, Inc.

BERMAN RICHARD JAdvaxis, Inc.

BIOGEN IDEC INCSUNESIS PHARMACEUTICALS INC

BIOGEN IDEC MA INCSUNESIS PHARMACEUTICALS INC

BJERKHOLT ERICSUNESIS PHARMACEUTICALS INC

Bonstein SaraAdvaxis, Inc.

Borellini FlaviaSUNESIS PHARMACEUTICALS INC

BORKOWSKI EDWARDACETO CORP

BRITTON WILLIAM NACETO CORP

Burcar MelodySUNESIS PHARMACEUTICALS INC

Company	Filed	Type	Qty	Price	Value · USD	Src
ACETO CORP	Sep 17, 2020	AwardD	30,000	0.00 USD	$0	SEC
ACETO CORP	Sep 17, 2020	Award	1,104,460	—	—	SEC